Virginia Judge Ships Suit Over AbbVie's Humira To Illinois

By Britain Eakin (October 22, 2021, 7:50 PM EDT) -- A Virginia federal judge on Friday transferred a declaratory judgment suit from a potential AbbVie Inc. rival hoping to make a biosimilar of its blockbuster immunosuppressant Humira to Illinois, saying the transfer order rendered a bid by AbbVie for dismissal moot.

U.S. District Judge Raymond A. Jackson said the balance of factors favored transferring Alvotech's suit seeking declarations that four AbbVie patents on adalimumab, Humira's active ingredient, are invalid and infringed. The opinion did not address AbbVie's request to dismiss Alvotech's suit, other than to say it was now moot.

AbbVie had asked the district court to dismiss the case back...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!